Point72 Hong Kong LTD Travere Therapeutics, Inc. Transaction History

Point72 Hong Kong LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$20.94 - $30.01 $113,892 - $163,224	-5,439 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$23.61 - $30.6 $123,551 - $160,129	5,233 Added 2540.29%	5,439 $140,000
Q4 2021 Feb 14, 2022	BUY	$24.34 - $31.17 $5,014 - $6,421	206 New	206 $6,000
Q3 2021 Nov 15, 2021	SELL	$12.98 - $25.03 $19,067 - $36,769	-1,469 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$14.11 - $26.4 $20,727 - $38,781	1,469 New	1,469 $21,000

192

84.5M

776K

900K

Ticker TVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,173,600
Market Cap $1.12B
Description
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.